SEC Tracker
Get the app

Innospec IOSP

Innospec Q3 FY23: revenue $464.1M; diluted EPS $1.57

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Innospec reported for Q3 FY23, the quarter ended Sep 30, 2023, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$464.1MNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Diluted EPS$1.57No year-earlier figure tagged10-Q income statement, on EDGAR
  3. Cash and cash equivalents$207.2MNo year-earlier figure tagged10-Q balance sheet, on EDGAR
  4. Cash from operations$58.1MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Innospec files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2800 and related industry codes: the same peer list as the financial tables.

  1. Ingevity NGVT public float $1.6B, Jun 30, 2025
  2. Chemours CC public float $1.7B, Jun 30, 2025
  3. Huntsman HUN public float $1.7B, Jun 30, 2025
  4. Ecovyst ECVT public float $933M, Jun 30, 2025
  5. Perimeter Solutions PRM public float $1.9B, Jun 30, 2025